The Opinions The Opinions

Why We Can’t Stop Arguing About S.S.R.I.s

Sep 16, 2026 · 42m

Summary

This episode of The Opinions features David Ross, Rachel Bedard, and Dr. Anthony Rostain discussing the widespread use of SSRIs and the current political debate surrounding psychiatric medication. The guests examine the evolution of these drugs, the shift from the "chemical imbalance" theory to neuroplasticity, and the challenges of safely tapering off medications. They argue that while SSRIs are useful tools, they are often misused or prescribed without adequate access to therapy and social support.

Topics discussed

Sponsor: Instacart and its new AI assistant Clementine Introduction: The debate on psychiatric drugs and therapy access RFK Jr.'s initiative to reduce psychiatric drug use in children Doctor's perspective: Prescribing meds due to lack of therapy access History of SSRIs: Safety improvements over previous drugs Efficacy and the shift from chemical imbalance to neuroplasticity Neuroplasticity: How meds help rewire brain circuits Patient fears about brain changes and identity The necessity of medication for severe pain and suffering Population-level effectiveness and the insulin analogy Treatment-resistant depression and unknown biological mechanisms The brain as a 'black box' and patient autonomy Why therapy is often more effective than medication alone Accessibility barriers: Pills vs. variable therapy quality The need for allies in mental health: Teachers and parents Social determinants: Loneliness and environmental causes Assessing if a patient is ready for therapeutic work Navigating the combative discourse around de-prescribing Misuse of stimulants and SSRIs without evidence Addressing misuse and the need for $1B in therapy access Building meaningful structures and reducing stigma Sponsor: NY Times subscription offer Criticism that the MAHA report was overdue The gap between best practice and real-world prescribing Long-term use: Short trials vs. lifelong medication needs Patient choice to stay on medication if it is working Assessing readiness to taper off medication Chronic conditions and individualized tapering plans Discontinuation syndrome and genetic factors in withdrawal Case study: Extremely slow tapering to avoid panic Over-medication of children: A serious but complex question Parental decision-making: Balancing risks and benefits Listening to the child's experience and side effects Common side effects: Blunting, sleep issues, and fogginess The black box warning and its impact on pediatric prescribing Distinguishing withdrawal symptoms from returning illness Managing diagnostic uncertainty during tapering Rising diagnosis rates vs. increased access and reduced taboo Societal factors: Pandemic, economy, and atomization Stigma and shame as risk factors for seeking help Holistic approach: Meds, therapy, and lifestyle changes The importance of social support and healthy lifestyle Humanism in medicine: Solving problems beyond pills Starting points: Schools, workplaces, and family support Demystifying mental health education for families Sponsor: Yale New Haven Health

More from The Opinions

Trump Got Together With the Boys
Nov 21, 2026
Anthropic’s $2 Trillion Debut: Bubble, Breakthrough or Both?
Nov 20, 2026
‘There’s No Juice Left to Squeeze From MAGA’
Nov 14, 2026
New Leaders Emerge for 2028
Nov 7, 2026
What Democrats Can Do Now to Lower Costs
Nov 6, 2026
Listen ad-free on Castria